These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19582718)

  • 1. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
    Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K
    Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma.
    Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Harada T; Fujimoto M; Sakaida I; Okita K; Oka M; Nakamura K
    Proteomics; 2006 Jul; 6(13):3894-900. PubMed ID: 16767786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis.
    Xiang Y; Sekine T; Nakamura H; Imajoh-Ohmi S; Fukuda H; Nishioka K; Kato T
    Arthritis Rheum; 2004 May; 50(5):1511-21. PubMed ID: 15146421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasticity of protein expression during culture of fetal skin cells.
    Vuadens F; Crettaz D; Scelatta C; Servis C; Quadroni M; Bienvenut WV; Schneider P; Hohlfeld P; Applegate LA; Tissot JD
    Electrophoresis; 2003 Apr; 24(7-8):1281-91. PubMed ID: 12707923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
    Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
    Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient proteomics-based approach for the screening of autoantibodies.
    Canelle L; Bousquet J; Pionneau C; Deneux L; Imam-Sghiouar N; Caron M; Joubert-Caron R
    J Immunol Methods; 2005 Apr; 299(1-2):77-89. PubMed ID: 15914192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis.
    Nakanishi T; Takeuchi T; Ueda K; Murao H; Shimizu A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):15-20. PubMed ID: 16707281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
    Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
    Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry.
    Mikuriya K; Kuramitsu Y; Ryozawa S; Fujimoto M; Mori S; Oka M; Hamano K; Okita K; Sakaida I; Nakamura K
    Int J Oncol; 2007 Apr; 30(4):849-55. PubMed ID: 17332923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
    Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis.
    Ahn BY; Song ES; Cho YJ; Kwon OW; Kim JK; Lee NG
    Proteomics; 2006 Feb; 6(4):1200-9. PubMed ID: 16421937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
    Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
    Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteomic approach based on multiple parallel separation for the unambiguous identification of an antibody cognate antigen.
    Mun J; Kim YH; Yu J; Bae J; Noh DY; Yu MH; Lee C
    Electrophoresis; 2010 Oct; 31(20):3428-36. PubMed ID: 20872419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
    BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody profiles as biomarkers of breast cancer.
    Tabernero MD; Lv LL; Anderson KS
    Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.